Loading...

FITC anti-human CD25 Antibody

Pricing & Availability
Clone
BC96 (See other available formats)
Regulatory Status
RUO
Workshop
V T-072
Other Names
Low affinity IL-2R, IL-2R α chain, Tac, p55
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
BC96_FITC_062107
PHA-stimulated (3 day) human peripheral blood lymphocytes were stained with CD25 (clone BC96) FITC (filled histogram) or mouse IgG1, κ FITC isotype control (open histogram).
  • BC96_FITC_062107
    PHA-stimulated (3 day) human peripheral blood lymphocytes were stained with CD25 (clone BC96) FITC (filled histogram) or mouse IgG1, κ FITC isotype control (open histogram).
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
302603 25 tests 44€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
302604 100 tests 95€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD25 is a 55 kD type I transmembrane glycoprotein also known as the low affinity IL-2 receptor α chain or Tac. It is expressed on progenitor lymphocytes, activated T and B cells, and activated monocytes/macrophages. CD25 is also expressed on a subset of non-stimulated CD4+ T cells termed T regulatory cells. CD25 associates with the IL-2 receptor β (CD122) and common γ chains (CD132) to form the high affinity IL-2R complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Reported Reactivity
Baboon, Chimpanzee, Cynomolgus, Pigtailed Macaque, Rhesus
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications include: immunocytochemistry3.

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  3. Ernst CW, et al. 2007. Clin. Exp. Immunol. 148:271. (ICC) PubMed
Product Citations
  1. Thiramanas R, et al. 2020. Cells. 9: . PubMed
  2. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  3. Gartshteyn Y, et al. 2023. Life Sci Alliance. 6: . PubMed
  4. Felce SL, et al. 2021. Wellcome Open Res. 5:42. PubMed
  5. Metelo AM, et al. 2022. Cancer Res Commun. 2:158. PubMed
  6. Donadei C, et al. 2023. J Clin Med. 12:. PubMed
  7. Garcia–Perez JE, et al. 2019. Front Immunol. 10:998. PubMed
  8. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  9. Kubo M, et al. 2018. Oncol Rep. 39:417. PubMed
  10. Pauthner MG, et al. 2019. Immunity. 50:241. PubMed
  11. Aqel SI, et al. 2021. JCI Insight. 6:e142376. PubMed
  12. Beswick E, et al. 2011. Infect Immun. 79:2737. PubMed
  13. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  14. Turner AW, et al. 2020. ACS Infect Dis. 6:1719. PubMed
  15. Miles B, et al. 2015. Nat Commun. 6: 8608. PubMed
  16. Grivas A, et al. 2022. Front Immunol. 13:964274. PubMed
  17. Hassani M, et al. 2020. Iran Biomed J. 24:81. PubMed
  18. Liu H, et al. 2021. J Immunother Cancer. 9:. PubMed
  19. Qu K et al. 2017. Cancer cell. 32(1):27-41 . PubMed
  20. Dai Z, et al. 2022. Signal Transduct Target Ther. 7:85. PubMed
  21. Grigoriou M, et al. 2021. Cancer Immunol Res. 9:726. PubMed
  22. Cirelli KM et al. 2019. Cell. 177(5):1153-1171 . PubMed
  23. Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
  24. Kim ST, et al. 2021. J Immunother Cancer. 9:. PubMed
  25. Csomós K, et al. 2022. Nat Immunol. 23:1256. PubMed
  26. Rhijn I, et al. 2016. Proc Natl Acad Sci U S A. 113: 380 - 385. PubMed
  27. Ryba M, et al. 2011. Cytokine. 55:353. PubMed
  28. Jiang J, et al. 2016. Sci Rep. 6: 32320. PubMed
  29. Businaro R, et al. 2009. Atherosclerosis. 207:74. PubMed
  30. Yost KE, et al. 2019. Nat Med. 25:1251. PubMed
  31. Meniailo M, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.023. PubMed
RRID
AB_314273 (BioLegend Cat. No. 302603)
AB_314273 (BioLegend Cat. No. 302604)

Antigen Details

Structure
Type I transmembrane glycoprotein, 55 kD
Distribution

Activated T cells and B cells, monocytes/macrophages, Treg

Function
Associates with IL-2 receptor β (CD122) and γ chains (CD132) to form high affinity IL-2R complex
Ligand/Receptor
IL-2
Cell Type
B cells, Macrophages, Monocytes, T cells, Tregs
Biology Area
Cell Biology, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References

1. Taniguchi T, et al. 1993. Cell 73:5.
2. Waldmann T. 1991. J. Biol. Chem. 266:2681.

Gene ID
3559 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD25
Specificity Alt (DOES NOT SHOW ON TDS):
CD25
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD25 on UniProt.org

Related FAQs

There are no FAQs for this product.

Customers Also Purchased

PE anti-human CD19
Clone: HIB19

APC anti-human CD4
Clone: RPA-T4

APC anti-human CD4
Clone: OKT4

PE anti-human CD69
Clone: FN50

Go To Top Version: 3    Revision Date: 12.15.2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account